EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 29 April 2019. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 3.95 for January-March 2019 as against Tk. 3.77 for January-March 2018; Consolidated EPS was Tk. 11.93 for July 2018-March 2019 as against Tk. 11.20 for July 2017-March 2018. Consolidated NOCFPS was Tk. 11.34 for July 2018-March 2019 as against Tk. 10.52 for July 2017-March 2018. Consolidated NAV per share was Tk. 81.95 as on March 31, 2019 and Tk. 73.28 as on June 30, 2018.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aced55a6b000040059f59
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.